GlassScriptPhysician profile
Richard W Townsend
NPI 1003885088
$1,938.68
in general payments reported to CMS, 2019-2025
28 companies · $36.44 in 2025
The $36.44 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $737 · 2021: $68.10 · 2022: $149 · 2023: $167 · 2024: $54.90 · 2025: $36.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $264.32 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $226.15 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $206.92 | 2019-2020 | |
| Amarin Pharma, INC. | $179.50 | 2019-2021 | |
| Lilly USA, LLC | $154.26 | 2019-2024 | Mounjaro, Trulicity, Jardiance |
| Abbvie INC. | $135.25 | 2020-2023 | Ubrelvy |
| Novartis Pharmaceuticals Corporation | $71.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.28 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $68.61 | 2019-2020 | |
| Glaxosmithkline, LLC. | $66.65 | 2019-2020 | |
| Amgen INC. | $58.12 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $54.34 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $50.36 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.89 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $34.97 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $32.92 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $29.06 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.33 | 2019 | |
| Astellas Pharma US INC | $24.60 | 2021 | |
| Allergan, INC. | $23.15 | 2019-2020 | |
| Bausch Health US, LLC | $21.48 | 2020 | |
| Exact Sciences Corporation | $18.45 | 2024 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $17.66 | 2025 | Inspire |
| Horizon Therapeutics Plc | $16.24 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $14.06 | 2019 | |
| Eisai INC. | $13.89 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.65 | 2019 | |
| Janssen Scientific Affairs, LLC | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Townsend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.